Jeffrey Modell Foundation Co-Hosts Global Artificial Intelligence Meeting
"This pivotal global meeting offered attendees the opportunity to learn more about the transformative potential of AI in supporting diagnosis and treatment of Primary Immunodeficiency (PI)," said
The meeting featured some of the world's leading experts presenting cutting-edge research on AI as it relates to the diagnosis, treatment, and management of PI and Inborn Errors of Immunity (IEI). Key program highlights included the use of AI and Machine Learning (ML) to improve diagnosis and treatment, integration of AI into clinical decision-making, ethical considerations in AI, and opportunities for continued global collaboration.
The Foundation also introduced its groundbreaking AI tool, the Modell Mind, which leverages advanced natural language processing to simplify querying, automate complex analyses, and explore trends, patterns, and patient demographics related to PI. The Modell Mind enables efficient decision-making, offers comprehensive insights, and will transform how the Foundation analyzes PI data.
"At JMF, our mission has always been to achieve the earliest possible diagnosis, giving patients the best chance at timely and effective treatment and care. In uniting global experts, we aim to encourage cross-institutional collaborations to close the gap created by data limitations and ensure a more accurate approach to early diagnosis," said Tenembaum.
About the Jeffrey Modell Foundation
Fred and the late
JMF is a global non-profit organization dedicated to early diagnosis, meaningful treatments and, ultimately, cures through research, physician education, public awareness, advocacy, patient support, newborn screening, and genetic sequencing. For more information visit https://info4pi.org/ or watch Do Something: The Jeffrey Modell Story online, available in seven languages.
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/jeffrey-modell-foundation-co-hosts-global-artificial-intelligence-meeting-302422379.html
SOURCE Jeffrey Modell Foundation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zone & Co Expands Zoe's Portfolio of AI Agents With AP Operations Across Procure-to-Pay
- EY US expands its strategic alliance with SymphonyAI to bring manufacturing intelligence to enterprise operations
- NS Pharma Parent Company, Nippon Shinyaku, Exercises Option Rights for Commercialization of AB2 BIO's Tadekinig alfa in the U.S.
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share